Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABT | Abbott Laboratories

IndexS&P 500 P/E33.37 EPS (ttm)2.94 Insider Own0.40% Shs Outstand1.74B Perf Week-3.53%
Market Cap171.85B Forward P/E21.23 EPS next Y4.62 Insider Trans-1.67% Shs Float1.73B Perf Month-6.64%
Income5.16B PEG- EPS next Q1.09 Inst Own76.20% Short Float / Ratio0.66% / 2.56 Perf Quarter-9.16%
Sales40.23B P/S4.27 EPS this Y-0.60% Inst Trans0.27% Short Interest11.47M Perf Half Y1.14%
Book/sh21.36 P/B4.60 EPS next Y5.19% ROA7.00% Target Price124.94 Perf Year-2.48%
Cash/sh4.66 P/C21.07 EPS next 5Y-2.10% ROE14.10% 52W Range93.25 - 115.83 Perf YTD-10.60%
Dividend2.04 P/FCF31.31 EPS past 5Y30.50% ROI13.00% 52W High-15.26% Beta0.68
Dividend %2.08% Quick Ratio1.20 Sales past 5Y9.80% Gross Margin55.20% 52W Low5.25% ATR1.54
Employees115000 Current Ratio1.60 Sales Q/Q-11.40% Oper. Margin15.20% RSI (14)28.37 Volatility1.30% 1.56%
OptionableYes Debt/Eq0.45 EPS Q/Q-31.30% Profit Margin12.80% Rel Volume0.97 Prev Close98.93
ShortableYes LT Debt/Eq0.39 EarningsJul 20 BMO Payout66.30% Avg Volume4.48M Price98.15
Recom2.00 SMA20-3.84% SMA50-7.14% SMA200-7.58% Volume4,356,793 Change-0.79%
Date Action Analyst Rating Change Price Target Change
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Apr-20-23Reiterated UBS Buy $117 → $130
Apr-20-23Reiterated Raymond James Outperform $116 → $123
Apr-20-23Reiterated JP Morgan Overweight $118 → $122
Apr-20-23Reiterated Bernstein Outperform $132 → $133
Apr-20-23Reiterated Barclays Overweight $125 → $127
Mar-29-23Initiated UBS Buy $117
Oct-26-22Initiated Mizuho Neutral $105
Today 09:15AM
Sep-22-23 09:13AM
08:48AM
Sep-21-23 05:50PM
12:02PM
09:30AM Loading…
09:30AM
Sep-20-23 12:00PM
11:07AM
10:18AM
08:00AM
Sep-19-23 10:30AM
08:00AM
Sep-15-23 02:55PM
10:10AM
09:15AM
05:20AM Loading…
05:20AM
Sep-14-23 07:32AM
07:14AM
07:06AM
Sep-13-23 02:30PM
09:30AM
Sep-12-23 09:45AM
Sep-11-23 05:50PM
09:00AM
08:30AM
Sep-09-23 05:00AM
Sep-07-23 01:15PM
Sep-06-23 10:27AM
Sep-05-23 05:50PM
04:30PM
12:00PM Loading…
12:00PM
Sep-04-23 12:18PM
Sep-02-23 06:00AM
Sep-01-23 09:09AM
Aug-31-23 02:08PM
12:54PM
10:41AM
10:36AM
09:30AM
08:30AM
Aug-30-23 05:50PM
Aug-29-23 09:00AM
Aug-28-23 12:09PM
11:37AM
Aug-26-23 10:20AM
Aug-24-23 05:50PM
10:13AM
Aug-23-23 09:30AM
Aug-19-23 08:23AM
06:05AM
Aug-17-23 09:41AM
Aug-16-23 09:00AM
Aug-15-23 09:38AM
Aug-14-23 04:49PM
02:36PM
11:44AM
11:31AM
09:01AM
Aug-11-23 10:20AM
08:48AM
05:14AM
Aug-10-23 01:24PM
10:00AM
Aug-09-23 11:12AM
11:03AM
08:21AM
08:17AM
Aug-08-23 03:38PM
Aug-07-23 10:25AM
07:01AM
Aug-06-23 09:00AM
Aug-04-23 12:26PM
12:20PM
09:49AM
09:01AM
09:00AM
Aug-03-23 02:02PM
01:16PM
01:03PM
12:57PM
11:22AM
11:16AM
11:12AM
11:00AM
10:53AM
10:14AM
Aug-02-23 12:28PM
11:51AM
11:28AM
11:25AM
10:44AM
09:00AM
08:48AM
08:00AM
Aug-01-23 12:15PM
12:12PM
11:27AM
11:02AM
10:44AM
07:29AM
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 08Option Exercise38.405,000192,00075,427Aug 10 06:31 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTAug 08Sale105.0310,4001,092,29765,027Aug 10 06:31 PM
STARKS DANIEL JDirectorJul 27Sale113.7650,0005,688,1896,775,316Jul 28 05:10 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMay 02Option Exercise47.008,226386,62278,653May 03 07:09 PM
STARKS DANIEL JDirectorMay 02Sale111.0250,0005,551,1936,825,316May 02 08:04 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMay 02Sale110.568,226909,47270,427May 03 07:09 PM
MANNING JOSEPH JEXECUTIVE VICE PRESIDENTMar 01Sale100.701,339134,83762,323Mar 02 07:40 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTMar 01Sale100.701,317132,62238,420Mar 02 07:13 PM
Funck, Jr. Robert E.EXECUTIVE VICE PRESIDENTMar 01Sale100.701,264127,285218,237Mar 02 07:35 PM
DALE MICHAEL DSENIOR VICE PRESIDENTMar 01Sale100.701,209121,74645,133Mar 02 07:25 PM
Watkin JaredSENIOR VICE PRESIDENTMar 01Sale100.701,198120,63971,366Mar 02 07:59 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01Sale100.701,085109,260119,861Mar 02 07:52 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTMar 01Sale100.701,069107,648175,959Mar 02 07:16 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMar 01Sale100.701,032103,92252,203Mar 02 08:04 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01Sale100.7094394,96075,437Mar 02 07:27 PM
Ginascol John FEXECUTIVE VICE PRESIDENTMar 01Sale100.7094394,960118,380Mar 02 07:36 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 01Sale100.7771772,25287,224Mar 02 07:45 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 01Sale100.7067968,37570,427Mar 02 07:57 PM
Tyler Julie L.SENIOR VICE PRESIDENTMar 01Sale100.7052552,86839,162Mar 02 07:55 PM
Tyler Julie L.SENIOR VICE PRESIDENTFeb 22Sale103.2426026,84240,896Feb 22 07:20 PM
Karam SammySENIOR VICE PRESIDENTDec 29Sale108.754,200456,75026,462Jan 03 05:32 PM
Ginascol John FEXECUTIVE VICE PRESIDENTDec 13Sale112.3211,0001,235,520111,912Dec 15 05:26 PM
STARKS DANIEL JDirectorOct 27Sale97.4650,0004,872,9326,873,500Oct 31 05:44 PM